March 31st marks the day in 1941 when the first radioiodine treatment was administered by Dr Saul Hertz at Massachusetts General Hospital.
During this day, let’s reflect on the historic first treatment, the current innovations already accessible to patients and the coming innovations in the field of Theragnostics.
Theragnostics are on the way to changing cancer care to be more individualised and patient-centric.
Curious to learn more about theragnostics? Check this out